Amgen Inc. (AMGN)
NASDAQ: AMGN · IEX Real-Time Price · USD
277.37
+3.43 (1.25%)
At close: May 1, 2024, 4:00 PM
279.00
+1.63 (0.59%)
After-hours: May 1, 2024, 6:09 PM EDT
Amgen Revenue
In the year 2023, Amgen had annual revenue of $28.19B with 7.09% growth. Revenue in the quarter ending December 31, 2023 was $8.20B with 19.84% year-over-year growth.
Revenue (ttm)
$28.19B
Revenue Growth
+7.09%
P/S Ratio
5.29
Revenue / Employee
$1,055,805
Employees
26,700
Market Cap
148.65B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 28.19B | 1.87B | 7.09% |
Dec 31, 2022 | 26.32B | 344.00M | 1.32% |
Dec 31, 2021 | 25.98B | 555.00M | 2.18% |
Dec 31, 2020 | 25.42B | 2.06B | 8.83% |
Dec 31, 2019 | 23.36B | -385.00M | -1.62% |
Dec 31, 2018 | 23.75B | 898.00M | 3.93% |
Dec 31, 2017 | 22.85B | -142.00M | -0.62% |
Dec 31, 2016 | 22.99B | 1.33B | 6.14% |
Dec 31, 2015 | 21.66B | 1.60B | 7.97% |
Dec 31, 2014 | 20.06B | 1.39B | 7.43% |
Dec 31, 2013 | 18.68B | 1.41B | 8.17% |
Dec 31, 2012 | 17.27B | 1.68B | 10.80% |
Dec 31, 2011 | 15.58B | 529.00M | 3.51% |
Dec 31, 2010 | 15.05B | 411.00M | 2.81% |
Dec 31, 2009 | 14.64B | -361.00M | -2.41% |
Dec 31, 2008 | 15.00B | 232.00M | 1.57% |
Dec 31, 2007 | 14.77B | 503.00M | 3.53% |
Dec 31, 2006 | 14.27B | 1.84B | 14.79% |
Dec 31, 2005 | 12.43B | 1.88B | 17.82% |
Dec 31, 2004 | 10.55B | 2.19B | 26.26% |
Dec 31, 2003 | 8.36B | 2.83B | 51.29% |
Dec 31, 2002 | 5.52B | 1.51B | 37.54% |
Dec 31, 2001 | 4.02B | 386.30M | 10.64% |
Dec 31, 2000 | 3.63B | 289.30M | 8.66% |
Dec 31, 1999 | 3.34B | 621.90M | 22.88% |
Dec 31, 1998 | 2.72B | 317.20M | 13.21% |
Dec 31, 1997 | 2.40B | 161.20M | 7.20% |
Dec 31, 1996 | 2.24B | 299.90M | 15.46% |
Dec 31, 1995 | 1.94B | 292.00M | 17.72% |
Dec 31, 1994 | 1.65B | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Elevance Health | 171.75B |
Pfizer | 58.50B |
Sanofi | 51.60B |
Novartis AG | 49.92B |
AstraZeneca | 47.61B |
Thermo Fisher | 42.86B |
Abbott Laboratories | 40.11B |
Danaher | 22.52B |
AMGN News
- 7 hours ago - Moody's, Booking, DraftKings, Amgen stocks in focus ahead of earnings - Invezz
- 11 hours ago - Amgen investors await weight-loss drug data - Reuters
- 11 hours ago - AMGEN HIGHLIGHTS NEW COPD, ASTHMA AND VASCULITIS RESEARCH AT ATS 2024 - PRNewsWire
- 1 day ago - Sandoz reaches agreement with Amgen over patent dispute - Reuters
- 2 days ago - AMGEN ANNOUNCES WEBCAST OF 2024 FIRST QUARTER FINANCIAL RESULTS - PRNewsWire
- 5 days ago - AMGEN TO SUBMIT TEPROTUMUMAB MARKETING AUTHORIZATION APPLICATION TO THE EUROPEAN MEDICINES AGENCY - PRNewsWire
- 8 days ago - FTC looking to accelerate inquiry into prescription-drug middlemen, chair says - Market Watch
- 14 days ago - Big pharma is looking to fatten profits with buyouts of weight-loss drug companies. Here are 4 candidates. - Market Watch